News tagged with adverse reactions

Signifor approved for Cushing's disease

(HealthDay)—Signifor (pasireotide diaspartate) has been approved by the U.S. Food and Drug Administration to treat Cushing's disease in cases that cannot be treated by surgery.

Dec 17, 2012
popularity not rated yet | comments 0

Xeljanz approved for rheumatoid arthritis

(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.

Nov 07, 2012
popularity not rated yet | comments 0

Abraxane approved to treat advanced lung cancer

(HealthDay)—Abraxane (paclitaxel protein-bound) has been approved by the U.S. Food and Drug Administration—in combination with the drug carboplatin—to treat advanced or spreading non-small cell lung ...

Oct 14, 2012
popularity not rated yet | comments 0

Profs aim to track drug reactions via social media

Experiencing nausea, headaches or other side effects from prescriptions or over-the-counter medicines? Researchers say tweeting about it or posting your concerns online could one day help alert drug companies and federal ...

Oct 03, 2012
popularity not rated yet | comments 0

Hopes that new substance will induce cancer cell suicide

(Medical Xpress)—The p53 gene plays a key role in the prevention of cancer, by blocking cell growth and triggering programmed cell death or apoptosis. If, however, p53 has mutated and become defective, the cancer cells ...

Sep 18, 2012
popularity not rated yet | comments 0 | with audio podcast

Kyprolis approved for multiple myeloma

(HealthDay) -- Kyprolis (carfilzomib) has been approved by the U.S. Food and Drug Administration to treat certain people with multiple myeloma who have already been given at least two prior therapies.

Jul 20, 2012
popularity not rated yet | comments 0